Article Details

Celldex Therapeutics, Inc. (CLDX) Receives Consensus Rating of “Hold” from Brokerages

Retrieved on: 2019-03-17 00:30:00

Tags for this article:

Click the tags to see associated articles and topics

Celldex Therapeutics, Inc. (CLDX) Receives Consensus Rating of “Hold” from Brokerages. View article details on HISWAI:

Excerpt

<div>Finally, <b>Two Sigma Investments</b> LP raised its position in shares of Celldex Therapeutics by 1.5% during the 4th quarter. <b>Two Sigma Investments</b> LP ...</div>

Article found on:

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up